ChromaDex Corporation
NASDAQ:CDXC
3.55 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 83.57 | 72.05 | 67.449 | 59.257 | 46.291 | 31.557 | 21.201 | 26.811 | 22.014 | 15.313 | 10.161 | 11.61 | 8.113 | 7.566 | 5.778 | 4.506 | 0 |
| Cost of Revenue
| 32.79 | 29.253 | 25.959 | 23.983 | 20.522 | 15.502 | 10.724 | 14.89 | 13.533 | 9.988 | 7.028 | 9.335 | 5.641 | 4.622 | 3.736 | 3.275 | 0 |
| Gross Profit
| 50.78 | 42.797 | 41.49 | 35.274 | 25.769 | 16.055 | 10.477 | 11.921 | 8.481 | 5.326 | 3.133 | 2.275 | 2.472 | 2.945 | 2.041 | 1.232 | 0 |
| Gross Profit Ratio
| 0.608 | 0.594 | 0.615 | 0.595 | 0.557 | 0.509 | 0.494 | 0.445 | 0.385 | 0.348 | 0.308 | 0.196 | 0.305 | 0.389 | 0.353 | 0.273 | 0 |
| Reseach & Development Expenses
| 4.958 | 4.826 | 3.832 | 3.732 | 4.42 | 5.478 | 4.007 | 2.523 | 0.892 | 0.514 | 0.134 | 0.142 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 24.983 | 28.286 | 36.379 | 30.448 | 34.308 | 27.137 | 17.642 | 9.393 | 7.416 | 8.375 | 5.117 | 8.392 | 7.797 | 3.876 | 2.104 | 2.579 | 0.038 |
| Selling & Marketing Expenses
| 26.438 | 28.313 | 28.352 | 20.948 | 18.216 | 16.537 | 4.459 | 2.251 | 2.327 | 2.137 | 2.358 | 5.52 | 2.539 | 1.086 | 0.83 | 0.721 | 0 |
| SG&A
| 47.721 | 56.599 | 64.731 | 51.396 | 52.524 | 43.674 | 22.101 | 11.644 | 9.743 | 10.511 | 7.475 | 13.912 | 10.336 | 4.962 | 2.934 | 3.3 | 0.038 |
| Other Expenses
| 0 | 2.085 | 0 | 0 | 0.125 | -0.065 | 0.746 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 52.679 | 61.425 | 68.563 | 55.128 | 57.069 | 49.227 | 26.854 | 14.167 | 10.635 | 10.511 | 7.475 | 13.912 | 10.336 | 4.962 | 2.934 | 3.3 | 0.038 |
| Operating Income
| -1.899 | -18.628 | -27.073 | -19.854 | -31.3 | -33.172 | -16.377 | -2.245 | -2.154 | -5.231 | -4.386 | -11.636 | -7.864 | -2.017 | -0.893 | -2.068 | -0.038 |
| Operating Income Ratio
| -0.023 | -0.259 | -0.401 | -0.335 | -0.676 | -1.051 | -0.772 | -0.084 | -0.098 | -0.342 | -0.432 | -1.002 | -0.969 | -0.267 | -0.155 | -0.459 | 0 |
| Total Other Income Expenses Net
| -3.039 | 2.088 | -0.055 | -0.071 | -0.847 | -0.065 | -0.746 | -0.313 | -0.613 | -0.046 | -0.045 | -0.026 | 0 | -0.035 | -0.015 | -0.036 | 0 |
| Income Before Tax
| -4.938 | -16.54 | -27.128 | -19.925 | -32.147 | -33.316 | -16.53 | -2.928 | -2.767 | -5.388 | -4.42 | -11.662 | 0 | -2.052 | -0.908 | -2.104 | -0.038 |
| Income Before Tax Ratio
| -0.059 | -0.23 | -0.402 | -0.336 | -0.694 | -1.056 | -0.78 | -0.109 | -0.126 | -0.352 | -0.435 | -1.004 | 0 | -0.271 | -0.157 | -0.467 | 0 |
| Income Tax Expense
| 1.537 | -2.091 | -1.571 | -1.442 | -0.676 | 0.223 | -4.847 | 0.313 | 0.005 | 0.203 | 0.078 | 0.026 | -0.001 | -0.002 | -0.002 | -0.034 | 0.038 |
| Net Income
| -4.938 | -14.449 | -25.557 | -18.483 | -31.471 | -33.316 | -11.378 | -2.928 | -2.771 | -5.388 | -4.42 | -11.662 | -7.895 | -2.052 | -0.908 | -2.104 | -0.038 |
| Net Income Ratio
| -0.059 | -0.201 | -0.379 | -0.312 | -0.68 | -1.056 | -0.537 | -0.109 | -0.126 | -0.352 | -0.435 | -1.004 | -0.973 | -0.271 | -0.157 | -0.467 | 0 |
| EPS
| -0.066 | -0.21 | -0.38 | -0.3 | -0.55 | -0.61 | -0.26 | -0.079 | -0.077 | -0.15 | -0.13 | -0.39 | -0.35 | -0.13 | -0.094 | -0.22 | -0.007 |
| EPS Diluted
| -0.066 | -0.21 | -0.38 | -0.3 | -0.55 | -0.61 | -0.26 | -0.079 | -0.077 | -0.15 | -0.13 | -0.36 | -0.35 | -0.13 | -0.094 | -0.22 | -0.007 |
| EBITDA
| -0.194 | -18.628 | -27.073 | -19.854 | -31.3 | -33.172 | -16.377 | -2.243 | -1.82 | -4.971 | -4.115 | -11.289 | -7.465 | -1.63 | -0.498 | -1.692 | -0.038 |
| EBITDA Ratio
| -0.002 | -0.259 | -0.401 | -0.335 | -0.676 | -1.051 | -0.772 | -0.084 | -0.083 | -0.325 | -0.405 | -0.972 | -0.92 | -0.215 | -0.086 | -0.375 | 0 |